Who invested in Sante Veritas Therapeutics?
Sante Veritas Therapeutics's investors include Canaccord Genuity Group.
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$16Mraised across 1 round since 2017, from 1 source
Sante Veritas Therapeutics's investors include Canaccord Genuity Group.
Sante Veritas Therapeutics has raised $16M across 1 round since 2017.
Sante Veritas Therapeutics's most recent round was a Venture of $16M in Dec 2017.
Its most recent round, $16M in Dec 2017, is also its largest on record.
Sante Veritas Therapeutics's first round on record, in Dec 2017, was backed by Canaccord Genuity Group.
Sante Veritas Therapeutics's latest named round is a Venture, in Dec 2017.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.